Uterine artery embolization--clinical problems

• Published in: Ginekologia polska Vol. 84; no. 12; p. 1051
• Main Authors: Woźniakowska, Ewa, Milart, Paweł, Paszkowski, Tomasz, Palacz, Tomasz, Woźniak, Sławomir, Wrona, Wojciech, Szkodziak, Piotr, Paszkowski, Maciej, Czuczwar, Piotr
• Format: Journal Article
• Language: English; Polish
• Published: Poland Wydawnictwo Via Medica 01-12-2013
• Subjects: Adult; Amenorrhea - etiology; Embolization; Female; Fibroids; Humans; Infertility - etiology; Leiomyoma - etiology; Menopause, Premature; Middle Aged; Necrosis - etiology; Pregnancy; Primary Ovarian Insufficiency - etiology; Uterine Artery Embolization - adverse effects; Uterus - pathology; Womens health
• ISSN: 0017-0011; 0017-0011; 2543-6767
• DOI: 10.17772/gp/1679

The aim of the study was to present clinical issues concerning uterine artery embolization (UAE) in women with uterine fibromas. In order to ensure high clinical efficiency of UAE and prevent subsequent complications, it is necessary to carefully select patients eligible for the procedure. Patients with intramural fibromas, who do not plan to conceive, are the best candidates for the procedure. Fibroma necrosis, with following infection, and premature ovarian failure remain to be the most common complications after UAE. UAE may cause amenorrhea and increase FSH levels, what is typical for menopause. Thus, it may be responsible for problems with conception as well as optimal development of a pregnancy. It may also cause premature, iatrogenic menopause. This complication significantly more frequently occurs in women over the age of 45 as compared to younger patients. UAE is considered as an alternative therapeutic procedure, available to women who do not desire the surgery or wish to preserve the uterus. Patients subject to this procedure should be informed about the possible side effects.